|
ID
|
Author
|
Year
|
Title
|
Publisher
|
| 2236790 |
Meyer Zu Schwabedissen, Henriette E; Boettcher, Kerstin; Steiner, Tobias; Schwarz, Ute I; Keiser, Markus; Kroemer, Heyo K; Siegmund, Werner |
2014 |
OATP1B3 is expressed in pancreatic β-islet cells and enhances the insulinotropic effect of the sulfonylurea derivative glibenclamide |
Diabetes |
| 4656044 |
Brouwer, Kim L R; Evers, Raymond; Hayden, Elizabeth; Hu, Shuiying; Li, Cindy Yanfei; Meyer Zu Schwabedissen, Henriette E; Neuhoff, Sibylle; Oswald, Stefan; Piquette-Miller, Micheline; Saran, Chitra; Sjöstedt, Noora; Sprowl, Jason A; Stahl, Simone H; Yue, Wei |
2022 |
Regulation of Drug Transport Proteins-From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium. |
Clinical pharmacology and therapeutics |
| 4622195 |
Jeiziner, Chiara; Wernli, Ursina; Suter, Katja; Hersberger, Kurt E; Meyer Zu Schwabedissen, Henriette E |
2021 |
HLA-associated adverse drug reactions - scoping review. |
Clinical and translational science |
| 4615202 |
Bachmann, Fabio; Duthaler, Urs; Meyer Zu Schwabedissen, Henriette E.; Puchkov, Maxim; Huwyler, Jörg; Haschke, Manuel; Krähenbühl, Stephan |
2021 |
Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2 |
Clinical Pharmacology and Therapeutics |
| 4622191 |
Huynh, Christine; Henrich, Andrea; Strasser, Daniel S.; Boof, Marie-Laure; Al-Ibrahim, Mohamed; Meyer Zu Schwabedissen, Henriette E.; Dingemanse, Jasper; Ufer, Mike |
2021 |
A Multipurpose First-in-Human Study With the Novel CXCR7 Antagonist ACT-1004-1239 Using CXCL12 Plasma Concentrations as Target Engagement Biomarker |
Clinical Pharmacology and Therapeutics |
| 4601494 |
Brecht, Karin; Schäfer, Anima Magdalena; Meyer zu Schwabedissen, Henriette E. |
2020 |
Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy - Modulators of Cellular Entry or Pharmacokinetics? |
Cancers |
| 4634827 |
Goers, Roland; Coman Schmid, Diana; Jäggi, Vera F; Paioni, Paolo; Okoniewski, Michal J; Parker, Althea; Bangerter, Beat; Georgakopoulou, Sofia; Sengstag, Thierry; Bielicki, Julia; Tilen, Romy; Vermeul, Swen; Krämer, Stefanie D; Berger, Christoph; Rinn, Bernd; Meyer Zu Schwabedissen, Henriette E |
2021 |
SwissPK; cdw; - A clinical data warehouse for the optimization of pediatric dosing regimens. |
CPT: pharmacometrics & systems pharmacology |
| 4523061 |
Nicolussi, Simon; Drewe, Jürgen; Butterweck, Veronika; Meyer zu Schwabedissen, Henriette E |
2020 |
Clinical relevance of St. John's wort drug interactions revisited. |
British journal of pharmacology |
| 4627070 |
Bachmann, Fabio; Meyer Zu Schwabedissen, Henriette E; Duthaler, Urs; Krähenbühl, Stephan |
2022 |
Cytochrome P450 1A2 is the most important enzyme for hepatic metabolism of the metamizole metabolite 4-methylaminoantipyrine. |
British journal of clinical pharmacology |
| 4492719 |
Duthaler, Urs; Suenderhauf, Claudia; Karlsson, Mats O.; Hussner, Janine; Meyer Zu Schwabedissen, Henriette; Krähenbühl, Stephan; Hammann, Felix |
2018 |
Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers |
British journal of clinical pharmacology |
| 2270890 |
Sternberg, Katrin; Petersen, Svea; Grabow, Niels; Senz, Volkmar; Meyer zu Schwabedissen, Henriette; Kroemer, Heyo K.; Schmitz, Klaus-Peter |
2013 |
Implant-associated local drug delivery systems based on biodegradable polymers: customized designs for different medical applications |
Biomedizinische Technik |
| 4634830 |
Huynh, Christine; Brussee, Janneke M; Pouzol, Laetitia; Fonseca, Marlene; Meyer Zu Schwabedissen, Henriette E; Dingemanse, Jasper; Sidharta, Patricia N |
2021 |
Target engagement of the first-in-class CXCR7 antagonist ACT-1004-1239 following multiple-dose administration in mice and humans. |
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie |
| 4642928 |
Mettler, Lina G; Brecht, Karin; Butterweck, Veronika; Meyer Zu Schwabedissen, Henriette E |
2022 |
Impact of the clinically approved Petasites hybridus extract Ze 339 on intestinal mechanisms involved in the handling of histamine. |
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie |
| 4605309 |
Ehrsam, Daniel; Sieber, Sandro; Oufir, Mouhssin; Porta, Fabiola; Hamburger, Matthias; Huwyler, Jörg; Meyer zu Schwabedissen, Henriette E. |
2020 |
Design, Synthesis, and Characterization of a Paclitaxel Formulation Activated by Extracellular MMP9 |
Bioconjugate Chemistry |
| 4510234 |
Ferreira, Celio; Meyer, Ramona; Meyer Zu Schwabedissen, Henriette E. |
2019 |
The nuclear receptors PXR and LXR are regulators of the scaffold protein PDZK1 |
Biochimica et biophysica acta. Gene regulatory mechanisms |
| 4105981 |
Malagnino, Vanessa; Hussner, Janine; Seibert, Isabell; Stolzenburg, Antje; Sager, Christoph P.; Meyer zu Schwabedissen, Henriette E. |
2018 |
LST-3TM12 is a member of the OATP1B family and a functional transporter |
Biochemical pharmacology |
| 3888980 |
Monzel, Judith V.; Budde, Thomas; Meyer zu Schwabedissen, Henriette E.; Schwebe, Mattihas; Bien-Möller, Sandra; Lütjohann, Dieter; Kroemer, Heyo K.; Jedlitschky, Gabriele; Grube, Markus |
2017 |
Doxorubicin enhance oxysterol levels resulting in a LXR-mediated upregulation of cardiac cholesterol transporters |
Biochemical pharmacology |
| 4622193 |
Kinzi, Jonny; Grube, Markus; Meyer Zu Schwabedissen, Henriette E. |
2021 |
OATP2B1 - The underrated member of the organic anion transporting polypeptide family of drug transporters? |
Biochemical Pharmacology |
| 2819159 |
Meyer zu Schwabedissen, Henriette E; Siegmund, Werner; Kroemer, Heyo K; Rollnik, Jens D |
2014 |
Creatine kinase elevation caused by a combination of fluvastatin and telmisartan in a patient heterozygous for the CYP2C9*3 and ABCC2 -24C < T variants: a case report. |
BMC Research Notes |
| 4510266 |
Ehrsam, Daniel; Porta, Fabiola; Mori, Matteo; Meyer zu Schwabedissen, Henriette E.; Dalla Via, Lisa; Garcia-Argaez, Aìda Nelly; Basile, Livia; Meneghetti, Fiorella; Villa, Stefania; Gelain, Arianna |
2019 |
Unravelling the Antiproliferative Activity of 1,2,5-oxadiazole Derivatives |
Anticancer Research |
